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Prenatal exposure to smoking has conse-
quences both in childhood and in adulthood
(1–5). Fetal exposure to cigarette smoke is
usually assessed by questionnaires adminis-
tered to mothers during or after pregnancy
(1,6). However, difficulties in recognizing
smoking behavior or recalling smoking expo-
sure, or changes in smoking habits during
gestation could bias these assessments.
In a country such as Spain, with a high
prevalence of young female smokers (7) and
a high passive intake through social events
(8), questionnaires could be even less valid.
In addition, pregnant women, conscious of
the risks of tobacco smoke products for the
fetus, may be reluctant to admit active
smoking or passive exposure due to social
pressure (9).
In recent years there has been increasing
interest in the use of biomarkers of smoking
exposure to improve the validity of assess-
ment by questionnaire (9–13). At present,
cotinine measured in blood, saliva, or urine
appears to be a reliable marker of recent
smoking status in population studies
(14–16). However, collection of saliva or
urine in newborns is rather unfeasible.
Two recent studies have measured coti-
nine in cord blood (9,11) and compared it
to self-reported maternal smoking. The ﬁrst
study (9) included 27 newborns from smok-
ing mothers, whereas the other study (11)
was carried out in a population with a low
intensity of smoking during pregnancy and
without measurement of exposure to envi-
ronmental tobacco smoke (ETS).
Within the framework of a cohort study
on the effects of prenatal and postnatal envi-
ronmental exposures in the inception of
atopy and asthma [Asthma Multicenter
Infant Cohort Study; AMICS (17)], we
aimed to measure prenatal exposure to tobac-
co smoke. For this purpose, cotinine was
measured in cord serum samples and mater-
nal and newborn urine collected on the day
of delivery and compared to maternal self-
reported questionnaires. The objective of the
present analysis was to assess the association
between these biomarkers of exposure, partic-
ularly cotinine in cord blood, and the quanti-
tative measurement of smoking intake and
exposure at the end of pregnancy measured
through questionnaire.
Materials and Methods
Subjects. Mothers and their newborns were
recruited for the AMICS study. Pregnant
women (n = 638; median age = 29 years)
attending the Hospital del Mar in Barcelona,
Spain, during 1997 and 1998 were invited
to participate if they anticipated living in the
city during the study years and had a tele-
phone. A total of 573 women had a term
newborn, accepted enrollment in the study,
and gave informed consent. Both parents
signed informed consent for their newborns.
Eligibility criteria included only single
births and a sufﬁcient amount (> 1 mL) of
one of the three biological samples collected,
which led to collection and analysis of 404
(70.5%) samples of cord serum, 226 (39.4%)
maternal urine samples, and 164 (29.0%)
newborn urine samples. In cases of cord
serum and maternal urine samples, no differ-
ences (p > 0.2) in maternal age, smoking
habits, or social class (based on occupation)
were found between included and excluded
participants. In the case of newborn urine
samples there was a lower percentage of non-
exposed nonsmokers in included participants
(27.4%) than in excluded participants
(37.4%), even if not statistically signiﬁcant
(p = 0.07).
The reduced number of urine samples
was due to difficulties experienced in their
collection (e.g., contemporary presence of
meconium in the collection bag, loss of seal-
ing in the bags during urine collection, fre-
quent irritations in female newborns, etc.).
General information on delivery (e.g., birth
weight, gestational age, etc.) was recorded
from hospital ﬁles.
Questionnaire information. An exhaus-
tive questionnaire including smoking habits
was completed at the ﬁrst antenatal care visit
to the hospital, usually during the third
trimester of pregnancy. Mothers were asked if
they were nonsmokers, occasional smokers, or
daily smokers. If they were daily smokers,
they were asked the average number of ciga-
rettes currently smoked per day and the brand
of cigarette. None of the mothers who
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This study investigated the association between biomarkers of fetal exposure to cigarette smoke at
the end of pregnancy, cotinine in cord serum and in maternal and newborn urine samples, and
quantitative measurement of smoking intake and exposure evaluated by maternal self-reported
questionnaire. Study subjects were 429 mothers and their newborns from a hospital in Barcelona,
Spain. A questionnaire including smoking habits was completed in the third trimester of preg-
nancy and on the day of delivery. Cotinine concentration in cord serum was associated with daily
exposure to nicotine in nonsmokers and with daily nicotine intake in smokers. The geometric
mean of cotinine concentration in cord serum statistically discriminated between newborns from
nonexposed and exposed nonsmoking mothers, and between these two classes and smokers, and
furthermore was able to differentiate levels of exposure to tobacco smoke and levels of intake
stratiﬁed in tertiles. Urinary cotinine levels in newborns from nonsmoking mothers exposed to
more than 4 mg nicotine daily were statistically different from levels in two other categories of
exposure. Cotinine concentration in urine from newborns and from mothers did not differentiate
between exposure and nonexposure to environmental tobacco smoke (ETS) in nonsmoking moth-
ers. Cord serum cotinine appeared to be the most adequate biomarker of fetal exposure to smok-
ing at the end of pregnancy, distinguishing not only active smoking from passive smoking, but
also exposure to ETS from nonexposure. Key words: cord blood, cotinine, daily exposure to nico-
tine, fetal exposure to cigarette smoke, nicotine daily intake, questionnaire, urine. Environ Health
Perspect 108:1079–1083 (2000). [Online 25 October 2000]
http://ehpnet1.niehs.nih.gov/docs/2000/108p1079-1083pichini/abstract.htmlsmoked reported smoking on a less-than-daily
basis (occasional smokers) or consumption of
cigars. Women who reported cessation of
smoking at the time of interview (20%) were
considered nonsmokers. Regarding exposure
to ETS, nonsmoking mothers were asked if
they were regularly exposed to ETS, where
and by whom (husband or other people in
the family or/and at work), the average num-
ber of cigarettes and the brand of cigarette
smoked by these people, and the average
hours of exposure. Tobacco consumption and
exposure to ETS were calculated as milligrams
nicotine daily intake (NDI) and milligrams
daily exposure to nicotine (DEN), respective-
ly. In the case of smoking mothers, the NDI
was obtained from the average number of cig-
arettes smoked per day multiplied by nicotine
content (in milligrams) of each cigarette (15).
In the case of nonsmoking mothers with a
passive exposure, DEN was calculated as NDI
of the active smoker in the environment of
the mother multiplied by the hours during
which exposure was reported to occur (as a
fraction of 24 hr) (18). If nonsmoking moth-
ers declared contact with more than one
smoker, the different exposures were added. A
shorter version of the AMICS questionnaire
(one page only) was administered the day of
delivery as a conﬁrmation of the previous one.
If there was disagreement between the two
questionnaires (n = 15, 3.5%), the second one
was considered to be the most reliable.
Urinary cotinine. Urine samples were
collected on the day of delivery. Samples
from newborns were obtained using a special
adhesive collection bag.
Samples were stored at –80°C until
analysis. Urinary cotinine was measured in
duplicate using a double antibody radioim-
munoassay according to a method described
by Van Vunakis et al. (19). The level of cross-
reactivity of the cotinine antibody with other
nicotine metabolites was less than 5%. The
detectable range of measurement from the
standard curve was 0.2–20 ng/mL cotinine,
with an interassay coefﬁcient of variation of
6–10%. Assays were performed without
knowledge of questionnaire response.
Samples, which at ﬁrst assay fell outside the
calibration curve, were opportunely diluted.
Creatinine was measured by enzymatic
colorimetric test (CREA, MPR1, creatinine
PAP; Boehringer Mannheim, Mannheim,
Germany), and urinary creatinine levels were
used to estimate urinary dilution. A cutoff of
50 ng/mL was employed for urinary cotinine
to distinguish active smokers from non-
smokers (20). 
Cord serum cotinine. Umbilical cord
blood was obtained at delivery and immedi-
ately centrifuged. Serum was collected and
stored at –80°C until analysis. Cord serum
cotinine was analyzed in duplicate by
radioimmunoassay as described above for
urine samples. A cutoff of 14 ng/mL was
used for cord serum cotinine to distinguish
active smokers from nonsmokers (11) and
one of 1 ng/mL cord serum cotinine to dis-
tinguish nonexposed nonsmokers from
exposed nonsmokers (4). 
Statistical methods. We compared
sociodemographic and clinical data of moth-
ers and newborns in terms of self-reported
smoking status using chi-square tests for cat-
egorical variables and analysis of variance
(ANOVA) statistics for continuous variables.
Because cotinine values did not follow a nor-
mal distribution (distribution skewed to the
right), cotinine concentrations were log
transformed to ﬁt a normal distribution. To
assess a dose–response relationship between
smoking habits and cotinine levels, groups of
DEN in nonsmoking mothers and groups of
NDI in smoking mothers were stratified
according to tertiles. Furthermore, to com-
pare cotinine concentrations among nonex-
posed nonsmokers, exposed nonsmokers,
and smokers, adjusting for potential con-
founders such as maternal age, sex of the
child, or creatinine levels, a multiple linear
regression analysis was conducted. The same
process was used to relate cotinine amounts
in cord blood, maternal and newborn urine,
and birth weight. To assess the form of the
association between cotinine levels in cord
serum and NDI, a nonparametric smooth
function was assessed using the Lowess
method. In addition, although out of the
scope of the study, we attempted to calculate
our optimal cutoff value to separate between
nonexposed and exposed nonsmokers in
relation to self-reported smoking status using
the receiver operating characteristic (ROC)
curve. An ROC curve was calculated consid-
ering the sensitivity as the percentage of
exposed nonsmokers detected and speciﬁcity
as the percentage of nonexposed nonsmokers
correctly classiﬁed.
All analyses were performed using Stata,
version 5.0 (StataCorp, College Station, TX). 
Results
Of the 429 pregnant women included in the
study, 34% reported daily smoking during
the last trimester of pregnancy, 32% declared
they were exposed to ETS, and 34% declared
they were nonsmokers not exposed to ETS
(Table 1). None of the demographic or
socioeconomic characteristics obtained by
questionnaire was significantly related to
maternal smoking status, whereas the percent-
age of previous abortions and birth weight of
the newborns were statistically different
between smokers and nonsmokers. 
Distribution of cotinine levels in differ-
ent biological matrices under examination
are reported in Table 2 as percentiles.
Table 3 presents cord serum cotinine
according to the cutoffs encountered in the
international literature used to distinguish
newborns of smoking mothers from new-
borns of nonsmoking mothers, and also to
indicate passive exposure in newborns of non-
smokers (4,11) in relation to the self-reported
questionnaire. In addition, a cutoff of 1.78
ng/mL obtained in this study from the ROC
curve to discriminate newborns from nonex-
posed and exposed nonsmokers (sensitivity
and speciﬁcity of 60%) was also included in
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Table 1. Characteristics of the study population according to self-reported smoking habits.
Nonexposed Exposed
nonsmokers nonsmokers Smokers
(n = 146) (n = 139) (n = 144)
Mothers
Age (mean ± SD) 28.7 ± 5.67 29.2 ± 5.57 28.6 ± 5.20
Father’s social class (%) n = 116 n = 124 n = 119
Professional 12.1 3.2 5.9
Managerial and technical 12.1 12.9 9.2
Skilled (nonmanual) 33.8 46.0 40.3
Skilled (manual) 19.8 20.2 23.5
Partly skilled 19.9 17.7 18.5
Unskilled 3.3 0 2.6
Previous abortions (%)
≥ 1 33.3 37.9 46.7*
Child
Male (%) 50.0 50.4 54.6
Order in family (%)
1 48.4 43.1 35.9
2 37.6 37.9 50.0
> 2 14.0 19.0 14.1
Birth weight in grams (mean ± SD) 3288.7 ± 495.2 3319.9 ± 433.1 3104.7* ± 405.0
Length in centimeters (mean ± SD) 49.3 ± 2.3 49.5 ± 2.2 49.0 ± 2.8
Cranial perimeter in centimeters (mean ± SD) 34.5 ± 1.9 34.6 ± 1.4 34.1 ± 1.5
Low weight (< 2,500 g) (%) 4.8 2.2 6.3
Premature (< 37 weeks) (%) 5.7 5.1 5.0
*p< 0.05 in relation to nonexposed nonsmokers.the table and compared with the value from
the literature. Urinary cotinine levels higher
than 50 ng/mL were observed in 14% of the
self-reported nonexposed nonsmokers and in
28% of self-reported exposed nonsmokers.
These values decreased to 2% and 17% when
urinary cotinine from newborns of nonex-
posed and exposed mothers, respectively, were
considered (data not shown).
Table 4 shows cotinine levels in cord
serum and in newborn and maternal urine in
relation to self-reported smoking habits. The
median level of cord serum cotinine among
the newborns of smoking mothers was more
than 30 times higher than that of newborns
from exposed nonsmokers, and almost 50
times higher than that of newborns from
nonexposed nonsmokers. In addition, an
increasing trend of median level of cord
serum cotinine was observed when stratify-
ing in tertiles in both milligrams DEN in
exposed nonsmokers and milligrams NDI in
smoking mothers. Results were confirmed
when considering geometric means of cord
serum cotinine in the three groups of new-
borns, adjusting for confounding factors.
Indeed, geometric mean of cotinine concen-
tration in cord serum was able to statistically
discriminate between newborns from nonex-
posed and exposed nonsmokers, and
between these two classes and smokers, and
furthermore was able to statistically differen-
tiate levels of exposure to tobacco smoke and
levels of intake stratiﬁed in tertiles. 
Urinary cotinine levels in newborns from
nonsmoking mothers exposed to more than
4 mg nicotine daily were statistically differ-
ent from levels within the other two cate-
gories of exposure. The same result was
obtained when examining urinary cotinine
levels of the mothers. However, whereas uri-
nary cotinine levels in newborns from smok-
ing mothers showed a statistical difference
with increasing values of NDI, geometric
means of cotinine concentration in maternal
urine showed a lower intensity of association
and did not display any statistical difference
among tertiles of NDI.
Figure 1 shows the association between
cotinine levels in cord blood and NDI in
smokers, which appears to be linear except
for a plateau at high levels of smoking.
Similar functions were obtained using uri-
nary cotinine.
The relationship between birth weight of
the newborns and concentration of cotinine
in cord serum, and in urine from newborns
and their mothers is presented in Table 5.
The median levels of the biomarker in each
of the biological fluids under examination
showed a decreasing trend with increasing
birth weight. In the highest tertile of birth
weight (> 3,500 g), the geometric mean of
cotinine in cord serum and newborn urine
adjusted for confounding factors was statisti-
cally different from those of newborns with a
weight < 3,000 g. There was no association
between cotinine in biological fluids from
newborns and mothers and length and cra-
nial perimeter of the baby (data not shown).
Discussion
Results from this study show that measure-
ment of cotinine levels in body fluids was
useful in predicting smoking habits at the
end of the pregnancy and hence the quanti-
tative fetal exposure to tobacco smoke. For
the ﬁrst time, the population was categorized
not only as smokers and nonsmokers, but
also with consideration of exposure to ETS
among nonsmokers.
Levels of cotinine in cord serum and
urine from newborns and mothers were gen-
erally higher than those observed in other
studies dealing with both active smoking and
exposure to ETS (9,11,21–23). In particular,
if we consider the cutoff of 1 ng/mL reported
by Bearer at al. (4) for cord serum to discern
between exposure and nonexposure to ETS,
less than 20% of newborns of nonsmoking
mothers who did not report any exposure
presented values of cord serum in the range
of 0.2–1 ng/mL, whereas the majority (75%)
of these newborns showed cord serum coti-
nine in the interval of passive exposure (1–14
ng/mL). Conversely, this last percentage
decreases to 35% if using the cutoff of 1.78
ng/mL obtained from the ROC curve. The
higher cutoff found for cotinine in cord
blood, in comparison with that of Bearer at
al. (4), might be explained mainly with the
technique used in this study for cotinine
measurement. In fact, a radioimmunoassay
was used that showed a certain cross-reactivi-
ty with trans-3´-hydroxycotinine, the other
urinary metabolite of nicotine in smokers
and nonsmokers (24). However, exposed
nonsmokers were classified better in the
interval of 1–14 ng/mL (79% within the
interval) than in the interval of 1.78–14
(52% within the interval). Indeed, this study
was not designed for cutoff calculation, and
because cord serum cotinine levels between
nonexposed and exposed nonsmokers are
extremely close if compared with intervals
between smokers and nonsmokers, it was
only possible to obtain a sensitivity and speci-
ﬁcity of 60%. Finally, 4% of newborns from
nonexposed nonsmokers and 8% of new-
borns from exposed nonsmokers had cord
serum cotinine in the interval corresponding
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Table 2. Cotinine in different biological matrices.
ND Percentile
No. (%) Min 5th 25th 50th 75th 95th Max
Cord blood (ng/mL) 404 1.98 < 0.20 0.65 1.45 3.08 41.15 325 910
Newborn urine (ng/mL) 164 0 0.81 1.97 6.59 16.89 207.75 893 2,000
Maternal urine (ng/mL) 226 0 0.84 3.04 6.75 19.10 714.00 2,000 2,000
Abbreviations: Max, maximum; Min, minimum; ND, nondetectable.
Table 3. Maternal smoking status by questionnaire and cord serum cotinine levels according to the cutoff established to distinguish exposition to ETS and active
smoking.
Cord serum cotinine (ng/mL)
Nondetectable levels Absence of exposition Passive smoking Active smoking
≤ 0.2 0.2–1a 0.2–1.78b 1–14a 1.78–14b > 14
Self-reported smoking habit No. (%) No. (%) No. (%)  No. (%)  No. (%) No. (%) 
Nonexposed nonsmokers 5 (3.7) 23 (17.2) 77 (57.5) 101 (75.4) 47 (35.1) 5 (3.7)
Exposed nonsmokers 3 (2.2) 14 (10.5) 50 (37.3) 106 (79.1) 70 (52.2) 11 (8.2)
Smokers 0 (0.0) 1 (0.7) 4 (2.9) 17 (12.5) 14 (10.3) 118 (86.8)
Total 8 (2.0) 38 (9.4) 131 (32.4) 224 (55.4) 131 (32.4) 134 (33.2)
aCutoff by Bearer et al. (4). bCutoff by our study.
Figure 1. Smoothed graph of NDI (mg/day) against
cord serum cotinine (ng/mL). 
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NDI (mg/day)to newborns from active smokers. Therefore,
even considering different cutoffs and thus
different degrees of nondetected exposure,
maternal unawareness and underestimation
of ETS exposure, as well as an unwillingness
to declare active smoking during pregnancy
have to be considered, in agreement with
other authors (9,11). These results were con-
ﬁrmed when urine samples were considered.
Indeed, not only did a high percentage of
mothers who did not report active smoking
nor exposure to ETS present urinary levels of
cotinine > 50 ng/mL [the cutoff to distin-
guish active smokers from nonsmokers
according to Jarvis et al. (20)], but a certain
percentage of newborns also had these high
levels. Furthermore, it must be stressed that
these cotinine levels could be conservative, as
cord serum and urine from mothers and
newborns were collected at the time of deliv-
ery. On the other hand, urinary dilution,
which can be greatly affected at delivery time,
must be taken into account as a bias for coti-
nine levels in urine. In this study, however,
geometric means adjusted for log creatinine
consistently matched median values.
Nonetheless, a self-reported smoking
habit was a signiﬁcant determinant of coti-
nine levels in the biological fluids under
examination. NDI was used as the measure
of tobacco consumption. This parameter is a
better indicator of active smoking than the
number of cigarettes smoked per day, as the
latter measure does not take into account
different tar and nicotine content in differ-
ent brands of cigarettes. 
Exposure to ETS in nonsmoking moth-
ers was measured by DEN as exposure to
NDI of surrounding smokers. Although this
measure probably overestimates exposure to
ETS if compared to consumption, its use in
this study may be seen as an attempt to
objectively measure source strength (number
of smokers and their smoking pattern) (12)
independent from different individual per-
ceptions. Clearly, DEN did not take into
account possible differences in air ﬂow, venti-
lation, and proximity to the smokers. Indeed,
the determination of these parameters should
have required the objective measurement of
indoor air nicotine in all possible microenvi-
ronments of exposition or the use of personal
monitoring of vapor-phase nicotine, which
was beyond the scope of the present study
(12). Furthermore, NDI and DEN did not
consider individual differences in both mater-
nal and fetal metabolism and elimination of
tobacco smoke products. For this reason and
due to problems of underreporting and mis-
reporting, the calculation of direct correla-
tions between questionnaire information and
levels of cotinine in different biological ﬂuids
was considered worthless, given that previous
attempts have not succeeded in obtaining
reasonable results (6,9,11).
It is well known that fetal growth may be
adversely affected by both maternal active and
passive smoking, and birth weight has been
found to be inversely correlated with both
neonatal and postneonatal mortality (25,26).
In this study birth weight was inversely associ-
ated to cotinine levels in biological fluids
under investigation. In particular, cord serum
and newborn urinary cotinine were able to
reliably discriminate different birth weight
tertiles. 
Some authors have questioned the use of
cotinine in body ﬂuids as a biomarker to val-
idate questionnaires on smoking habits due
to limitations related to its use. These
include a generally short half-life so that only
recent exposure or consumption can be rep-
resented; considerable intersubject variability
in uptake, metabolism, and elimination; and
the fact that cotinine is not the active agent
in causing adverse health effects (12). In
addition, there is a lack of linear relationship
between cord serum cotinine and nicotine
daily intake at high smoking levels (ceiling
effect). However, in our study cord serum
cotinine was able to indicate the quantity of
both active and passive maternal exposure.
Furthermore, the ceiling effect in measures
of smoking intensity does not constitute a
problem in epidemiologic follow-up studies,
where the aim is to refine the detection at
low levels of smoking consumption or of
passive smoking, and to detect deceivers. 
The use of a biomarker at delivery would
certainly underestimate smoking consump-
tion or exposition earlier in pregnancy and
this period could be relevant with regard to a
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Table 4. Differences of cotinine levels (ng/mL) in biological matrices and self-reported smoking habits during pregnancy.
Cord serum cotinine Newborn urinary cotinine Maternal urinary cotinine
Self-reported Adjusted Adjusted  Adjusted
smoking habit No. Median GMa No. Median GMb No. Median GMb
Nonexposed nonsmokers 134 1.62 1.72 45 8.56 8.26 66 8.76 11.81
Exposed nonsmokers 134 2.40 2.76* 59 10.26 12.37 79 14.33 17.22
DENc (tertiles)
≤ 2 53 1.63 1.90 17 6.70 6.19 25 9.93 11.61
2–4 46 2.48 3.03** 24 9.97 9.92 29 13.83 13.51
> 4 35 3.80 4.43** 18 17.32 30.87** 25 19.33 34.35**
Smokers 136 73.80 59.33* 60 440.25 307.44* 81 1155.00 543.28*
NDId (tertiles)
≤ 3.6 49 40.00 31.16 22 153.30 160.65 33 650.00 336.26
3.6–9 63 81.90 73.07*** 29 633.00 514.80*** 33 1373.00 799.10
> 9 24 154.80 137.44*** 9 611.30 568.36*** 15 1970.00 925.57
GM, geometric mean.
aAdjusted for maternal age and sex of child. bAdjusted for log creatinine, maternal age, and sex of child. cDEN (mg nicotine) =
dNDI (mg nicotine) = mg nicotine/cigarette × number cigarettes smoked/day.
*p < 0.05 in relation to nonexposed nonsmokers. **p < 0.05 in relation to ﬁrst tertile of DEN. ***p < 0.05 in relation to ﬁrst tertile of NDI.
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Table 5. Association between birth weight and cotinine (ng/mL) measured in cord serum and in maternal and newborn urine.
Cord serum cotinine Newborn urinary cotinine Mother urinary cotinine
Adjusted Adjusted  Adjusted 
Birth weight (g) No. Median GMa No. Median GMb No. Median GMb
< 3,000  97 3.90 10.23 45 70 58.28 55 202.00 92.30
3,000–3,499 153 3.07 7.53 63 16.57 36.17 91 19.35 63.79
≥ 3,500 90 2.61 3.47* 38 12.45 17.38* 54 16.73 30.71
GM, geometric mean.
aAdjusted for maternal age and sex of child. bAdjusted for log creatinine, maternal age, and sex of child. *p < 0.05 in relation to ﬁrst tertile of birth weight.number of outcomes. Indeed, 20% of the
women in our study reported quitting smok-
ing cigarettes during pregnancy (usually ﬁrst
trimester). Determination of nicotine in hair
of mothers could clarify this issue, evidencing
eventual changes in smoking habits during
pregnancy, expecially when performing analy-
ses of different hair sections corresponding to
different periods of gestation. In addition,
nicotine in the hair of mothers can be com-
pared to newborn hair nicotine, which could
account for all periods of fetal exposure (12).
In any case, if mothers who gave up smoking
produced any bias in the association between
cotinine levels and the eventual effects in chil-
dren (birth weight in the present analysis), this
bias would be conservative.
We believe that the accurate assessment
of fetal exposure to smoking through the
objective measure of a biomarker could be of
major importance in a cohort such as this
one, in which the ultimate goal is the investi-
gation of the effects of prenatal and postnatal
environmental exposures to pollutants,
including tobacco smoke, in the inception of
atopy and asthma. In conclusion, both cord
serum cotinine and newborn urinary coti-
nine appeared to be adequate biomarkers
due to their ability to be associated with lev-
els of active smoking, levels of passive mater-
nal exposure to smoking, and to neonatal
effects such as birth weight. However, only
cord serum cotinine was able to discriminate
active smoking from exposure to ETS and
exposure from nonexposure, possibly
because of higher statistical power due to the
higher number of samples collected. Finally,
the ease of collection of cord blood com-
pared to the collection of urine from new-
borns, and the need to adjust for an eventual
dilution in the case of urine samples, which
requires a further creatinine assay, advocate
for the extension of the use of cord serum
cotinine as a biomarker of prenatal exposure
to smoking.
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